UnitedHealth Group reported second-quarter adjusted earnings of $6.38 per share. Revenue reached $112.03 billion, surpassing analyst expectations. The company raised its full-year 2026 guidance, citing improved margins and lower medical costs.
Management doubled the 2026 share repurchase target to at least $5 billion.
Several major financial firms increased their price targets following the report. Bank of America raised its target to $512. Morgan Stanley increased its price outlook to $529. Goldman Sachs, UBS, RBC, Truist, and Oppenheimer also issued higher price targets.